A Multinational Study to Measure the Value that Patients with Cancer Place on Improved Emesis Control Following Cisplatin Chemotherapy

Author： Dranitsaris G.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.9, 2001-01, pp. : 955-967

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomics of cisplatin-based chemotherapy in ovarian cancer patients of different ethnic origins

By Khrunin Andrey   Ivanova Feodosia   Moisseev Alexey   Khokhrin Denis   Sleptsova Yuliya   Gorbunova Vera   Limborska Svetlana  

Pharmacogenomics, Vol. 13, Iss. 2, 2012-01 ,pp. : 171-178

Future Medicine

Access to resources Recommend Favorite

Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer

By Kang Byung  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1671-1675

Springer Publishing Company

Access to resources Recommend Favorite

Anti-Emetics for Cancer Chemotherapy-Induced Emesis: Potential of Alternative Delivery Systems

By Kraut L.   Fauser A.A.  

Drugs, Vol. 61, Iss. 11, 2001-01 ,pp. : 1553-1562

Adis International

Access to resources Recommend Favorite

Value of budesonide demonstrated in multinational study

By  

Inpharma, Vol. 1, Iss. 1361, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Value of budesonide demonstrated in multinational study

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 385, 2002-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite